A prospective study was conducted over a 30-month period, in which fecal specimens from 6,750 patients were submitted to the Department of Microbiology at St. Vincent's Hospital, Sydney, Australia. Trophozoites of Dientamoeba fragilis were detected in 60 (0.9%) patients by permanent staining, and confirmation was performed by PCR. Gastrointestinal symptoms were present in all patients, with diarrhea and abdominal pain the most common symptoms. Thirty-two percent of patients presented with chronic symptoms. The average age of infected patients was 39.8 years. No correlation was found between D. fragilis and Enterobius vermicularis, a proposed vector of transmission for D. fragilis. The genetic diversity of 50 D. fragilis isolates was examined by PCR, and the PCR products were analyzed for the presence of restriction fragment length polymorphisms. These results showed no variation in the small-subunit rRNA gene and demonstrated a single genotype for all Australian isolates. This study shows the potential pathogenic properties of D. fragilis and the need for all laboratories to routinely test for this organism.Dientamoeba fragilis is a trichomonad parasite found in the gastrointestinal tract of humans and implicated as a cause of gastrointestinal disease. Dientamoeba fragilis has been found in most parts of the world in both rural and cosmopolitan areas (10). The prevalence of this organism in Australia varies greatly, from 0.4% to 16.8%, in patients presenting with gastrointestinal complaints (1,22).No cyst stage has been observed, and only the trophozoites are detected in stool samples. Definitive diagnosis is based on prompt fixation and permanent staining, as the trophozoites degenerate rapidly, within hours of been passed, and demonstration of their characteristic nuclear structure cannot be achieved in unstained preparations (24). Daily shedding of D. fragilis trophozoites has been shown to be highly variable, with intermittent shedding occurring regularly, necessitating multiple sampling for maximum chances of detection (20).Molecular techniques for the diagnosis of D. fragilis show much promise, with PCR demonstrating excellent sensitivity and specificity (18). Such techniques have been used successfully for the diagnosis of other pathogenic protozoa (11,19).Molecular genotyping and sequence analysis have demonstrated that D. fragilis exists as two genetically distinct forms (9,15,18,26). Stark et al. (18) sequenced the SSU rRNA gene of seven Australian D. fragilis isolates, and the data generated from the seven showed no variation among them. These observations support the notion that D. fragilis is a clonal species. The sequences from the Australian isolates, however, differed from the sequence of the D. fragilis strain Bi/PA (ATCC 30948; GenBank accession no. U37461) and were found to be similar to those found in a recent study in the Netherlands (15). The true incidence of the wild-type and variant forms in Australia needs to be established and to determine if such variation has any influence on the pa...